Welcome to our dedicated page for Simulations Plus SEC filings (Ticker: SLP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Simulations Plus, Inc. (Nasdaq: SLP) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures, including annual and quarterly reports, proxy statements, and current reports on Form 8‑K. As a California corporation in the professional, scientific, and technical services sector, Simulations Plus files with the U.S. Securities and Exchange Commission under file number 001‑32046.
Annual reports on Form 10‑K and quarterly reports on Form 10‑Q give detailed information on the company’s software and services segments, revenue mix, cost structure, research and development spending, and risk factors related to its biosimulation, cheminformatics, and consulting activities. These filings also describe the integration of AI/ML, PBPK, QSP/QST, and related modeling approaches that underpin its model‑informed and AI‑accelerated drug development offerings.
Proxy statements (DEF 14A) include information on board elections, auditor ratification, and equity incentive plans. For example, the company’s definitive proxy statement details proposals such as increasing shares authorized under the 2021 Equity Incentive Plan, board and committee structures, corporate governance practices, and executive compensation frameworks.
Current reports on Form 8‑K disclose material events such as changes in the independent registered public accounting firm, preliminary financial results and guidance, executive employment agreements, and scheduling of earnings releases and conference calls. These documents help investors understand governance decisions, auditor transitions, and key operational updates.
On Stock Titan, these filings are paired with AI‑powered summaries that highlight important points from lengthy documents, helping readers quickly identify items such as segment performance discussions, non‑GAAP reconciliations, equity plan amendments, and auditor changes. Users can also review filings related to compensation and equity awards, as well as other disclosures that shape the regulatory and governance profile of Simulations Plus.
Simulations Plus, Inc. (SLP) reported an insider equity award. A Form 4 discloses that Chief Revenue Officer John Anthony DiBella received stock options to purchase 27,500 shares at an exercise price of $16.02 on 10/16/2025.
The options expire on 10/15/2035 and vest in four equal annual installments, with one-fourth vesting on each anniversary of the grant date. Following the reported transaction, 27,500 derivative securities are beneficially owned directly.
Form 144 notice for Simulations Plus, Inc. (SLP): An insider proposes to sell 20,000 shares of Common stock through Morgan Stanley Smith Barney on 10/01/2025 with an aggregate market value of $301,400.00. The shares were originally acquired as Founders Shares from the issuer on 07/01/1996. The filing reports 20,127,110 shares outstanding for the class and indicates no securities sold in the past three months by the reporting person. The filer certifies no undisclosed material adverse information and follows the Rule 144 notice format for proposed sale reporting.
Simulations Plus director Lisa LaVange reported the sale of 867 shares of the company's common stock on 09/02/2025. The Form 4 states the shares were sold in a single transaction at $14.10 per share and that the sale was effected automatically pursuant to a Rule 10b5-1 trading plan. Following the reported transaction, Ms. LaVange beneficially owns 9,063 shares and holds those shares in a direct ownership form. The filing indicates the reporter is a director and the Form 4 was executed by an attorney-in-fact on 09/04/2025.
FAQ
What is the current stock price of Simulations Plus (SLP)?
What is the market cap of Simulations Plus (SLP)?
